OMVELIN Trademark

Trademark Overview

On Wednesday, December 21, 2011, a trademark application was filed for OMVELIN with the United States Patent and Trademark Office. The USPTO has given the OMVELIN trademark a serial number of 85501216. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 23, 2020. This trademark is owned by AstraZeneca AB. The OMVELIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infections, gastrointestinal diseases and disorders, and nervous system diseases and disorders
omvelin

General Information

Serial Number85501216
Word MarkOMVELIN
Filing DateWednesday, December 21, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 23, 2020
Registration Number4496810
Registration DateTuesday, March 18, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infections, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-151 85
SE

Trademark Events

Event DateEvent Description
Friday, October 23, 2020CANCELLED SEC. 8 (6-YR)
Monday, March 18, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 18, 2014REGISTERED-PRINCIPAL REGISTER
Saturday, February 8, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, December 18, 2013NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 31, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 18, 2013TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, March 31, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 29, 2013EXAMINER'S AMENDMENT ENTERED
Friday, March 29, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2013EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, October 15, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 15, 2012FINAL REFUSAL E-MAILED
Monday, October 15, 2012FINAL REFUSAL WRITTEN
Monday, October 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2012ASSIGNED TO LIE
Tuesday, October 2, 2012ASSIGNED TO LIE
Monday, September 24, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 9, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 9, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 27, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

omvelin disorders diseases substances pharmaceutical preparations treatment gastrointestinal nervous infections system